Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,443 papers from all fields of science
Search
Sign In
Create Free Account
CAND1 gene
Known as:
cullin-associated and neddylation-dissociated 1
, KIAA0829
, TIP120A
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
CAND2 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation
Nadezhda Tikhmyanova
,
S. Tutton
,
+6 authors
P. Lieberman
PLoS Pathogens
2017
Corpus ID: 28088397
The chemical probe C60 efficiently triggers Epstein-Barr Virus (EBV) reactivation from latency through an unknown mechanism. Here…
Expand
2016
2016
Single cell genotyping of exome sequencing-identified mutations to characterize the clonal composition and evolution of inv(16) AML in a CBL mutated clonal hematopoiesis.
Christoph Niemöller
,
N. Renz
,
+10 authors
H. Becker
Leukemia research : a Forum for Studies on…
2016
Corpus ID: 3283778
2016
2016
DCUN1D3 activates SCFSKP2 ubiquitin E3 ligase activity and cell cycle progression under UV damage
Shuai Zhang
,
Jing Huang
,
+6 authors
Xiaoyan Qiu
OncoTarget
2016
Corpus ID: 3452936
Our previous study showed that knockdown the endogenous expression of DCUN1D3 (also called SCCRO3 or DCNL3) blocked the S phase…
Expand
2013
2013
Regulation of Cullin-RING ubiquitin ligase 1 by Spliceosome-associated protein 130 (SAP130)
L. Cordero-Espinoza
,
T. Hagen
Biology Open
2013
Corpus ID: 1565938
Summary Cullin-RING ubiquitin ligases (CRLs) mediate the ubiquitination of numerous protein substrates and target them for…
Expand
2011
2011
Recruitment of the inhibitor Cand1 to the cullin substrate adaptor site mediates interaction to the neddylation site
K. Helmstaedt
,
Elke Schwier
,
+6 authors
G. Braus
Molecular Biology of the Cell
2011
Corpus ID: 16083801
Cand1 can be separated into two functional polypeptides. C-terminal Cand1 binds first at the cullin adaptor site. N-terminal…
Expand
2011
2011
Regulation of Cullin RING E3 Ubiquitin Ligases by CAND1 In Vivo
Yee Shin Chua
,
B. K. Boh
,
Wanpen Ponyeam
,
T. Hagen
PLoS ONE
2011
Corpus ID: 673593
Cullin RING ligases are multi-subunit complexes consisting of a cullin protein which forms a scaffold onto which the RING protein…
Expand
2008
2008
Association of SAP130/SF3b-3 with Cullin-RING ubiquitin ligase complexes and its regulation by the COP9 signalosome
Suchithra Menon
,
T. Tsuge
,
N. Dohmae
,
K. Takio
,
N. Wei
BMC Biochemistry
2008
Corpus ID: 10222123
BackgroundCullin-RING ubiquitin E3 ligases (CRLs) are regulated by modification of an ubiquitin-like protein, Nedd8 (also known…
Expand
2007
2007
Regulation of SCFSKP2 Ubiquitin E3 Ligase Assembly and p27KIP1 Proteolysis by the PTEN Pathway and Cyclin D1
J. Jonason
,
Nadia Gavrilova
,
Min Wu
,
Hui Zhang
,
Hong Sun
Cell Cycle
2007
Corpus ID: 33999930
The PTEN tumor suppressor functions as a phosphatase of phosphatidylinositol 3,4,5-trisphosphate (PIP3) and negatively regulates…
Expand
2004
2004
Arabidopsis ETA 2 , an Apparent Ortholog of the Human Cullin-Interacting Protein CAND 1 , Is Required for Auxin Responses Mediated by the SCFTIR 1 Ubiquitin Ligase
Huey-Wen Chuang
,
Wenjing Zhang
,
W. Gray
2004
Corpus ID: 20812514
Auxin response in Arabidopsis thaliana requires the SCFTIR1 ubiquitin ligase. In response to the hormone, SCFTIR1 targets members…
Expand
1999
1999
Induced expression, localization, and chromosome mapping of a gene for the TBP-interacting protein 120A.
S. Yogosawa
,
K. Kayukawa
,
+5 authors
T. Tamura
Biochemical and Biophysical Research…
1999
Corpus ID: 25911487
TBP-interacting protein 120A (TIP120A) is a novel eukaryotic transcriptional regulator and has been suggested to be involved in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE